Related Experiment Video
Updated: Aug 11, 2025
06:55
A Surgical Procedure for the Administration of Drugs to the Inner Ear in a Non-Human Primate Common Marmoset Callithrix jacchus
Published on: February 27, 2018
8.7K
Intratympanic Dexamethasone in Sudden Sensorineural Hearing Loss
Sonika Kanotra1,2, Ashwini Kumar1,2, Bhavna Langar3,2
1Department of E.N.T., Head and Neck Surgery, Government Medical College, Jammu, Jammu, 180001 India.
Summary
Intratympanic dexamethasone offers effective treatment for sudden sensorineural hearing loss (SSNHL). This method shows high recovery rates as both initial therapy and salvage treatment after oral steroids fail.
Area of Science:
- Otolaryngology
- Neurology
- Pharmacology
Background:
- Sudden sensorineural hearing loss (SSNHL) requires prompt intervention.
- Systemic steroids are standard but have side effect concerns.
- Intratympanic steroid injections are an alternative delivery method.
Purpose of the Study:
- To evaluate intratympanic dexamethasone (IT-Dexa) for SSNHL.
- To assess IT-Dexa as primary therapy and salvage treatment.
Main Methods:
- Prospective study of 39 SSNHL patients.
- Group 1: Oral steroids followed by IT-Dexa if unresponsive.
- Group 2: IT-Dexa for delayed presentation or comorbidities.
Main Results:
- Oral steroids achieved 56.5% hearing improvement.
- IT-Dexa primary therapy resulted in 62.5% recovery.
- IT-Dexa salvage therapy achieved 80% recovery.
- Delayed treatment negatively correlated with hearing recovery.
Conclusions:
- Intratympanic dexamethasone is safe and effective for SSNHL.
- Recommend IT-Dexa as primary and salvage treatment.
- Emphasize early initiation of treatment for optimal outcomes.
